Pharma & Healthcare

Global Tasigna Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Tasigna, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tasigna.
The Tasigna market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tasigna market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tasigna manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novartis
Segment by Type
50mg
200mg
Other
Segment by Application
Hospital
Drugs Store
Other
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tasigna manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tasigna in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Tasigna Market Overview
1.1 Product Definition
1.2 Tasigna by Type
1.2.1 Global Tasigna Market Value Comparison by Type (2024 VS 2031)
1.2.2 50mg
1.2.3 200mg
1.2.4 Other
1.3 Tasigna by Application
1.3.1 Global Tasigna Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Tasigna Market Size Estimates and Forecasts
1.4.1 Global Tasigna Revenue 2020-2031
1.4.2 Global Tasigna Sales 2020-2031
1.4.3 Global Tasigna Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tasigna Market Competition by Manufacturers
2.1 Global Tasigna Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tasigna Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tasigna Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tasigna, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tasigna, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tasigna, Product Type & Application
2.7 Global Key Manufacturers of Tasigna, Date of Enter into This Industry
2.8 Global Tasigna Market Competitive Situation and Trends
2.8.1 Global Tasigna Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tasigna Players Market Share by Revenue
2.8.3 Global Tasigna Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tasigna Market Scenario by Region
3.1 Global Tasigna Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tasigna Sales by Region: 2020-2031
3.2.1 Global Tasigna Sales by Region: 2020-2025
3.2.2 Global Tasigna Sales by Region: 2026-2031
3.3 Global Tasigna Revenue by Region: 2020-2031
3.3.1 Global Tasigna Revenue by Region: 2020-2025
3.3.2 Global Tasigna Revenue by Region: 2026-2031
3.4 North America Tasigna Market Facts & Figures by Country
3.4.1 North America Tasigna Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tasigna Sales by Country (2020-2031)
3.4.3 North America Tasigna Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Tasigna Market Facts & Figures by Country
3.5.1 Europe Tasigna Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tasigna Sales by Country (2020-2031)
3.5.3 Europe Tasigna Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tasigna Market Facts & Figures by Region
3.6.1 Asia Pacific Tasigna Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tasigna Sales by Region (2020-2031)
3.6.3 Asia Pacific Tasigna Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tasigna Market Facts & Figures by Country
3.7.1 Latin America Tasigna Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tasigna Sales by Country (2020-2031)
3.7.3 Latin America Tasigna Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tasigna Market Facts & Figures by Country
3.8.1 Middle East and Africa Tasigna Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tasigna Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tasigna Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tasigna Sales by Type (2020-2031)
4.1.1 Global Tasigna Sales by Type (2020-2025)
4.1.2 Global Tasigna Sales by Type (2026-2031)
4.1.3 Global Tasigna Sales Market Share by Type (2020-2031)
4.2 Global Tasigna Revenue by Type (2020-2031)
4.2.1 Global Tasigna Revenue by Type (2020-2025)
4.2.2 Global Tasigna Revenue by Type (2026-2031)
4.2.3 Global Tasigna Revenue Market Share by Type (2020-2031)
4.3 Global Tasigna Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tasigna Sales by Application (2020-2031)
5.1.1 Global Tasigna Sales by Application (2020-2025)
5.1.2 Global Tasigna Sales by Application (2026-2031)
5.1.3 Global Tasigna Sales Market Share by Application (2020-2031)
5.2 Global Tasigna Revenue by Application (2020-2031)
5.2.1 Global Tasigna Revenue by Application (2020-2025)
5.2.2 Global Tasigna Revenue by Application (2026-2031)
5.2.3 Global Tasigna Revenue Market Share by Application (2020-2031)
5.3 Global Tasigna Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Tasigna Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Tasigna Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tasigna Industry Chain Analysis
7.2 Tasigna Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tasigna Production Mode & Process Analysis
7.4 Tasigna Sales and Marketing
7.4.1 Tasigna Sales Channels
7.4.2 Tasigna Distributors
7.5 Tasigna Customer Analysis
8 Tasigna Market Dynamics
8.1 Tasigna Industry Trends
8.2 Tasigna Market Drivers
8.3 Tasigna Market Challenges
8.4 Tasigna Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tasigna Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tasigna Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tasigna Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tasigna Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tasigna Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tasigna Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tasigna Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tasigna Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tasigna, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tasigna, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tasigna, Product Type & Application
Table 12. Global Key Manufacturers of Tasigna, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tasigna by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tasigna as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tasigna Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tasigna Sales by Region (2020-2025) & (K Units)
Table 18. Global Tasigna Sales Market Share by Region (2020-2025)
Table 19. Global Tasigna Sales by Region (2026-2031) & (K Units)
Table 20. Global Tasigna Sales Market Share by Region (2026-2031)
Table 21. Global Tasigna Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tasigna Revenue Market Share by Region (2020-2025)
Table 23. Global Tasigna Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tasigna Revenue Market Share by Region (2026-2031)
Table 25. North America Tasigna Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tasigna Sales by Country (2020-2025) & (K Units)
Table 27. North America Tasigna Sales by Country (2026-2031) & (K Units)
Table 28. North America Tasigna Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tasigna Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tasigna Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tasigna Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tasigna Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tasigna Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tasigna Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tasigna Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tasigna Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tasigna Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tasigna Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tasigna Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tasigna Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tasigna Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tasigna Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tasigna Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tasigna Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tasigna Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tasigna Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tasigna Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tasigna Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tasigna Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tasigna Sales (K Units) by Type (2020-2025)
Table 51. Global Tasigna Sales (K Units) by Type (2026-2031)
Table 52. Global Tasigna Sales Market Share by Type (2020-2025)
Table 53. Global Tasigna Sales Market Share by Type (2026-2031)
Table 54. Global Tasigna Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tasigna Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tasigna Revenue Market Share by Type (2020-2025)
Table 57. Global Tasigna Revenue Market Share by Type (2026-2031)
Table 58. Global Tasigna Price (USD/Unit) by Type (2020-2025)
Table 59. Global Tasigna Price (USD/Unit) by Type (2026-2031)
Table 60. Global Tasigna Sales (K Units) by Application (2020-2025)
Table 61. Global Tasigna Sales (K Units) by Application (2026-2031)
Table 62. Global Tasigna Sales Market Share by Application (2020-2025)
Table 63. Global Tasigna Sales Market Share by Application (2026-2031)
Table 64. Global Tasigna Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tasigna Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tasigna Revenue Market Share by Application (2020-2025)
Table 67. Global Tasigna Revenue Market Share by Application (2026-2031)
Table 68. Global Tasigna Price (USD/Unit) by Application (2020-2025)
Table 69. Global Tasigna Price (USD/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Tasigna Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Novartis Tasigna Product
Table 74. Novartis Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Tasigna Distributors List
Table 78. Tasigna Customers List
Table 79. Tasigna Market Trends
Table 80. Tasigna Market Drivers
Table 81. Tasigna Market Challenges
Table 82. Tasigna Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
Table 86. Authors List of This Report


List of Figures
Figure 1. Product Picture of Tasigna
Figure 2. Global Tasigna Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tasigna Market Share by Type: 2024 & 2031
Figure 4. 50mg Product Picture
Figure 5. 200mg Product Picture
Figure 6. Other Product Picture
Figure 7. Global Tasigna Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Tasigna Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Drugs Store
Figure 11. Other
Figure 12. Global Tasigna Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Tasigna Market Size (2020-2031) & (US$ Million)
Figure 14. Global Tasigna Sales (2020-2031) & (K Units)
Figure 15. Global Tasigna Average Price (USD/Unit) & (2020-2031)
Figure 16. Tasigna Report Years Considered
Figure 17. Tasigna Sales Share by Manufacturers in 2024
Figure 18. Global Tasigna Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Tasigna Players: Market Share by Revenue in Tasigna in 2024
Figure 20. Tasigna Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Tasigna Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Tasigna Sales Market Share by Country (2020-2031)
Figure 23. North America Tasigna Revenue Market Share by Country (2020-2031)
Figure 24. the United States Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Tasigna Sales Market Share by Country (2020-2031)
Figure 27. Europe Tasigna Revenue Market Share by Country (2020-2031)
Figure 28. Germany Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. UK Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Tasigna Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Tasigna Revenue Market Share by Region (2020-2031)
Figure 35. China Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Tasigna Sales Market Share by Country (2020-2031)
Figure 45. Latin America Tasigna Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Tasigna Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Tasigna Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Tasigna Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Tasigna by Type (2020-2031)
Figure 55. Global Revenue Market Share of Tasigna by Type (2020-2031)
Figure 56. Global Tasigna Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Tasigna by Application (2020-2031)
Figure 58. Global Revenue Market Share of Tasigna by Application (2020-2031)
Figure 59. Global Tasigna Price (USD/Unit) by Application (2020-2031)
Figure 60. Tasigna Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies